Akathisia vs. Tardive Dyskinesia: Symptoms, Types, & Treatments

Both can appear after taking antipsychotic medication, but their timing and treatments differ. Knowing the distinction can help you get the right support.

Akathisia and tardive dyskinesia are neurological movement disorders that can develop as side effects of certain dopamine-blocking medications, particularly antipsychotics. Because both can involve restlessness, twitching, or repetitive movements, they’re often mistaken for one another at the very moment when clarity matters most.

For many people taking medication to stabilize mood, unexpected pacing, facial movements, or an uncomfortable inner agitation can be alarming — and it’s not always apparent whether it’s akathisia, tardive dyskinesia, or something else entirely. Yet these conditions have very different timelines, underlying causes, and treatment approaches.

Understanding the differences isn’t just about naming symptoms; it’s about knowing when to speak up, what to ask for, and how to get the right kind of help. Here’s a simple breakdown to help you feel more informed and supported.

Types of Akathisia and Tardive Dyskinesia

Timing is a critical differentiator: Akathisia is typically an “early” responder that starts quickly after medication changes, while tardive dyskinesia is a “delayed” reaction that appears after long-term use. Both are linked to dopamine-blocking drugs, but the biological mechanisms differ.

Akathisia Types

The name akathisia comes from the Greek word akathemi (“inability to sit”). Because the timing can vary, there are four specific subtypes, as listed by Cleveland Clinic:

• Acute akathisia develops shortly after you start an antipsychotic medication or increase the dose.
• Tardive akathisia begins three or more months after you start a new drug or dose.
• Withdrawal akathisia occurs after stopping medication or reducing your dose.
• Chronic akathisia lasts six months or more.

Tardive Dyskinesia Types

As the name “tardive” (late-onset) suggests, this movement disorder typically emerges after weeks, months, or years of medication use. However, there is a specific variation noted in research:

• Withdrawal-emergent dyskinesia begins after abruptly stopping medication after long-term use. According to a review published in Neuropsychiatric Disease and Treatment, this affects 4 to 67 percent of patients.
• Tardive dyskinesia syndrome is an umbrella term that encompasses stereotypies, chorea, dystonia, tics, or tremors — not as timing-based subtypes, but as distinct movement variants within the same condition.

Signs and Symptoms

The key difference is in the type of movement and how it feels. Akathisia creates an overwhelming inner urge to move that feels voluntary but impossible to ignore, often leading to fidgeting or pacing. Tardive dyskinesia, by contrast, causes involuntary, irregular muscle spasms — like twitchy, dancelike motions — affecting the face, mouth, or body that you may not even notice at first.​

Akathisia Symptoms 

Akathisia makes it feel impossible to stay still, notes a review article. Its name comes from the Greek “akathemi,” meaning “inability to sit.” This severe inner restlessness can create overwhelming unease, panic, or dysphoria, often leading to constant fidgeting that looks voluntary but reflects deep distress. For many taking antipsychotics, this torment can increase agitation, depression, and even suicidality — making it essential to talk with your doctor promptly.

While it’s an internal feeling, it results in visible external behaviors, such as persistent fidgeting.

• Physical Signs Repetitive leg movements are common. You might rock from leg to leg, march in place, or constantly cross and uncross your legs to ease the tension.
• Internal Experience Everyday situations, like standing still in a waiting line, can feel overwhelming, as if your body is urgently telling you to move.
• Mental Impact Studies link the symptoms of akathisia to worse agitation, depression, and higher suicidal thoughts, especially in men. 

Tardive Dyskinesia Symptoms 

On the other hand, tardive dyskinesia movements are described in a CNS Spectrums review as irregular, dancelike, and writhing, occurring without your control. The National Organization for Tardive Dyskinesia further reports that symptoms can appear from head to toe.

• Face and Mouth Up to 80 percent of cases involve blinking, lip smacking, cheek puffing, tongue darting, or jaw grinding — movements that can feel embarrassing once noticed.
• Limbs and Body Expect arm or leg swaying, finger “piano playing,” or torso rocking, like an unwanted internal dance.
• Internal Experience Many people don’t realize it’s happening until others point it out. But once they do become aware, the symptoms can cause significant social anxiety and social consciousness in daily life, according to a review article.

Causes and Risk Factors

Dopamine-blocking medications trigger both akathisia and tardive dyskinesia, but the biological mechanism — and who is most at risk — varies, suggests a research review and analysis.

Causes

• The Shared Trigger Both conditions are usually triggered by the same types of medicine: antipsychotics and anti-nausea drugs, such as metoclopramide (Reglan, Gimoti).

What’s Happening Inside the Brain?

• The Mechanism of Akathisia (the “Inner Restlessness”) Research notes that experts believe that akathisia occurs when there is an imbalance among brain chemicals (serotonin, GABA, and dopamine). Other theories involve neuroinflammation, overstimulation of brain regions involved in movement, damage to the blood-brain barrier, or impaired ability to generate new neurons.
• The Mechanism of Tardive Dyskinesia (the “Jerky Movements”) The leading theory, according to a review of existing studies, is that dopamine receptors in the brain become hypersensitive after long-term dopamine blockade, leading the brain to misfire and cause twitchy, erratic movements you can’t control. Oxidative stress or toxicity within key brain regions may also contribute.

Who Is Most at Risk?

Akathisia and tardive dyskinesia aren’t limited to just one diagnosis. According to experts, they can affect anyone who takes antipsychotic medications for conditions such as schizophrenia or schizoaffective disorder, depression, eating disorders, personality disorders, or stomach issues.

General Risks (for Everyone)

According to Mayo Clinic, you are generally at higher risk for both conditions if:

• You take older, first-generation (typical) antipsychotics.
• You are on a high dose.
• Your doctor increased your dose very quickly. 

Specific Risks for Akathisia

• Age Matters You are more likely to experience this if you are middle-aged or older.

Specific Risks for Tardive Dyskinesia

• Demographics Statistics show higher rates in women, Black individuals, and people over age 45.
• Health History You are also at higher risk if you have diabetes or a history of substance use issues.

How Are Both Conditions Diagnosed?

Diagnosis relies heavily on careful observation and what you describe about your symptoms. Because akathisia and tardive dyskinesia can mimic anxiety, agitation, or other issues, getting the correct label is key to avoiding missteps that could make things worse.

Spotting either one early can make a real difference in managing it and protecting your quality of life.

Screening Basics

Both are diagnosed clinically by a trained provider, but they rely on different tools. The Abnormal Involuntary Movement Scale (AIMS) is the go-to for tardive dyskinesia, while akathisia requires a dedicated scale, such as the Barnes Akathisia Rating Scale (BARS). AIMS spots general abnormal movements but doesn’t tease apart tardive dyskinesia from akathisia, so it’s not the main tool for restlessness.

Tardive Dyskinesia

Clinicians check for exposure to dopamine-blocking drugs (like antipsychotics), tardive dyskinesia-style movements (repetitive face, tongue, jaw, or limb motions), and rule out other causes. They document it with AIMS, rating movements by body area and severity. The National Alliance on Mental Illness (NAMI) recommends screening every three months if you’re on antipsychotics, since symptoms can sneak up late.

Akathisia

Diagnosing akathisia hinges on your report of inner restlessness — like feeling “driven” or unable to sit still — plus visible signs like pacing, rocking, or leg-fidgeting. Providers use BARS to rate your subjective distress, objective movements, and overall severity.

The Danger of Misdiagnosis

• Akathisia often gets mistaken for worsening anxiety, panic, bipolar agitation, restless legs syndrome, ADHD, or other neurological disorders with similar symptoms, the Akathisia Alliance notes. If it’s diagnosed as agitation, for example, the medication dose may be increased, which worsens the condition and increases suicide risk.
• Tardive dyskinesia might appear to onlookers as nervous tics or compulsions. Mistaking it for drug-induced Parkinsonism could mean medications that amplify the problem, as noted in CNS Spectrums.

Treatment Options

Akathisia and tardive dyskinesia often call for very different — sometimes opposite — treatment approaches. Akathisia, mainly when triggered by dopamine-blocking medications, may ease when dopamine is restored or when the nervous system is calmed. Tardive dyskinesia, however, can worsen if dopamine is increased, so treatments typically aim to dial it down gently. 

The first step in treating akathisia or tardive dyskinesia is to work with your doctor on a plan to adjust the dose, taper, or switch the antipsychotic medication that’s triggering the movements, according to the American Association of Psychiatric Pharmacists. 

After that adjustment, the rest of your treatment will depend on the specific biology of the condition you’re experiencing.

Treatment for Akathisia 

A review published in Schizophrenia Bulletin concluded that the best treatments for akathisia are:

• Serotonin 5-HT2a receptor antagonists, which might affect serotonin transmission in the brain
• Beta-blockers, which might influence dopamine transmission in the brain
• Benzodiazepines, which might reduce overactivity in the nervous system, according to a review article 
• Vitamin B6, which might aid movement disorders by influencing neurotransmitters or reducing inflammation in the brain, as suggested by a pilot study 

Another study review and meta-analysis found that mirtazapine (Remeron), an antidepressant, combined with the anticholinergic medication biperiden (Akineton) and vitamin B6, had the best combination of efficacy and tolerability in reducing the severity of akathisia. 

Vitamin B6 had the best risk-benefit profile because it was effective by helping correct dopamine imbalances while minimizing the risk of side effects.

Treatment for Tardive Dyskinesia

Tardive dyskinesia treatments aim to lower dopamine activity or calm specific twitchy muscles, often starting with tweaks to your current medications. The goal is noticeable relief without adding new burdens, so work closely with your psychiatrist to find what works best for your stability. 

• Switching Antipsychotics If you’re currently taking a first-generation antipsychotic, your prescribing doctor may decide to move you to a second-generation one, which tends to carry a lower risk. 
• VMAT2 Inhibitors The U.S. Food and Drug Administration (FDA) has approved two medications — valbenazine (Ingrezza) and deutetrabenazine (Austedo) — to help ease tardive dyskinesia by lowering excess dopamine activity in the brain. These VMAT2 inhibitors have been shown in randomized controlled trials to reduce involuntary movements, and many people notice improvement within weeks. It’s still important to monitor for potential side effects, such as drowsiness.
• Botox Doctors sometimes prescribe botulinum toxin injections to help control specific involuntary muscle movements, reports Penn Medicine.
• Transcranial Direct Current Stimulation (tDCS) This noninvasive brain stimulation uses mild electrical currents via scalp electrodes to modulate overactive motor areas, showing promise in reducing tardive dyskinesia symptoms in small studies.

How Long Does It Last? (Prognosis)

Akathisia is often reversible when recognized and managed early, whereas tardive dyskinesia is frequently persistent and can become permanent in some people.

Akathisia Prognosis 

According to StatPearls, the outlook for recovery is good once the triggering medication is stopped, particularly for acute akathisia. Chronic or tardive akathisia can be much more persistent.

• Acute akathisia is usually short-lived and can improve fairly quickly with appropriate treatment. Medications such as diazepam (Valium) or gabapentin enacarbil (Horizant) have been shown to reduce symptoms within weeks in many people, according to a review of existing research.

Tardive Dyskinesia Prognosis 

Tardive dyskinesia is more likely to be reversible if treated early, according to a clinical review article. 

• Early recognition and management improve the chances that tardive dyskinesia symptoms will lessen or resolve, but many people continue to have at least some ongoing movements despite treatment.
• Tardive dyskinesia can persist for months or longer after reducing or stopping the causative medication, and in some individuals it becomes permanent, according to a review article.

What Should You Do If You Notice Symptoms?

• Act early. Report any new or unusual movements to your healthcare provider, suggests Cleveland Clinic, especially if they occur after a change in medication.
• Discuss your options. Ask your doctor about adjusting your dose, switching medications, or adding treatments to counter movement symptoms.
• Do not stop or change medications. It’s essential to discuss any medication changes with your physician first. 

The Takeaway

• Akathisia feels like an intense inner urge to move that drives pacing or fidgeting even when you don’t want to, while tardive dyskinesia involves involuntary movements you may not notice at first.
• Trained doctors use special checklists to catch early signs of both, so make sure you’re getting regular check-ins to stay ahead.
• If your provider mistakes these for just anxiety or fidgety habits, tweaking your medications the wrong way could worsen symptoms — speak up if it feels off.
• You might find relief from akathisia with beta-blockers or benzodiazepines, while tardive dyskinesia often responds better to VMAT2 inhibitors.
• Akathisia often improves once the medication is adjusted, but tardive dyskinesia can persist, so catching it early is essential. 

Editorial Sources and Fact-Checking

• Akathisia. Cleveland Clinic. August 5, 2022.
• Caroff SN. Overcoming Barriers to Effective Management of Tardive Dyskinesia. Neuropsychiatric Disease and Treatment. April 4, 2019.
• Chen CY et al. Tardive Syndrome: An Update and Mini-Review. Journal of the Chinese Medical Association. December 2020. 
• Bjarke J. Akathisia and Atypical Antipsychotics: Relation to Suicidality, Agitation, and Depression in a Clinical Trial. Acta Neuropsychiatrica. May 20, 2022.
• Hauser RA et al. Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice. CNS Spectrums. November 20, 2020.
• About Tardive Dyskinesia. National Organization for Tardive Dyskinesia. 
• Caroff SN. A New Era in the Diagnosis and Treatment of Tardive Dyskinesia. CNS Spectrums. October 24, 2022.
• Martino D et al. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis. The Canadian Journal of Psychiatry. May 14, 2018.
• Salem H et al. Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges. Current Neuropharmacology. July 2017. 
• Debrey SM et al. Tardive Dyskinesia: Spotlight on Current Approaches to Treatment. Psychiatry Online. January 28, 2021.
• Gregory SY. Understanding Tardive Dyskinesia, From Symptoms to Causes and Prevention. Mayo Clinic. August 26, 2024.
• Chakrabarty AC et al. Increasing Abnormal Involuntary Movement Scale (AIMS) Screening for Tardive Dyskinesia in an Outpatient Psychiatry Clinic: A Resident-Led Outpatient Lean Six Sigma Initiative. Cureus. May 25, 2023.
• Barnes Akathisia Rating Scale. Movement Disorders in Psychiatry.
• Tardive Dyskinesia. National Alliance on Mental Illness. January 16, 2024.
• Akathisia: A Comprehensive Guide for Clinicians. Akathisia Alliance. December 2021.
• Chaney L. Drug-Induced Movement Disorders. American Association of Psychiatric Pharmacists. November 2021.
• Furukawa Y et al. Comparative Efficacy and Acceptability of Treatment Strategies for Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-analysis. Schizophrenia Bulletin. June 13, 2024.
• Thippaiah S et al. Struggling to Find Effective Pharmacologic Options for Akathisia? B-CALM! Psychopharmacology Bulletin. June 1, 2021. 
• Alizadeh N et al. Effect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A Pilot Comparative Double-Blind Study. Iranian Journal of Pharmaceutical Research. January 2018.
• Gerolymose C et al. Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis. JAMA Network Open. March 7, 2024.
• Solmi M et al. Treatment of Tardive Dyskinesia with VMAT-2 Inhibitors: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Drug Design, Development and Therapy. May 14, 2018.
• Tardive Dyskinesia. Penn Medicine.
• Lyu X et al. Transcranial Direct Current Stimulation Improves Tardive Dyskinesia in Long-Term Hospitalized Patients With Chronic Schizophrenia. Clinical Neurophysiology. October 2024.
• Patel J et al. Akathisia. StatPearls. July 24, 2023.
• Musco S et al. Dopamine-Receptor Blocking Agent–Associated Akathisia: A Summary of Current Understanding and Proposal for a Rational Approach to Treatment. Therapeutic Advances in Psychopharmacology. 2020.
• Kremens D. Earlier Diagnosis of Tardive Dyskinesia. The Psychiatrist. December 10, 2019.
• Cornett E et al. Medication-Induced Tardive Dyskinesia: A Review and Update. Ochsner Journal. Summer 2017. 
• Movement Disorders. Cleveland Clinic. March 23, 2023.